R. Dickinson

发表

Electrophysiologic Properties of UK‐66,914, a Novel Class III Antiarrhythmic Agent

M. Gwilt, P. Cross, R. Burges, 1991, Journal of cardiovascular pharmacology.

Endothelin attenuates apoptosis in human smooth muscle cells.

J. R. Wu-wong, W. Chiou, T. Opgenorth, 1997, The Biochemical journal.

An international survey of the educational activities of schools of pharmacy on psychoactive drugs.

A. Ghodse, R. Dickinson, J. Falkowski, 1989, Bulletin of the World Health Organization.

UK-37, 248, a novel, selective thromboxane synthetase inhibitor with platelet anti-aggregatory and anti-thrombotic activity.

M. Parry, M. Randall, P. Cross, 1981, Thrombosis research.

A novel series of highly selective inhibitors of MMP-3.

G. Whitlock, K. Dack, Mark L. Lewis, 2007, Bioorganic & medicinal chemistry letters.

The design and synthesis of a novel series of indole derived selective ETA antagonists

K. Dack, K. James, R. Dickinson, 2002 .

Promotion of carbohydrate oxidation in the heart by some phenylglyoxylic acids.

D. Stopher, J. Danilewicz, P. Cross, 1981, Journal of medicinal chemistry.

Novel antifungal 2-aryl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol derivatives with high activity against Aspergillus fumigatus

A. Bell, P. Troke, C. Hitchcock, 1996 .

Chapter 10 Thromboxane Synthetase Inhibitors and Antagonists

P. Cross, R. Dickinson, 1987 .

Selective urokinase-type plasminogen activator (uPA) inhibitors. Part 3: 1-isoquinolinylguanidines.

P. Fish, C. Barber, R. Dickinson, 2004, Bioorganic & medicinal chemistry letters.

Cerebrovasodilatation through selective inhibition of the enzyme carbonic anhydrase. 3. 5-(Arylthio)-, 5-(arylsulfinyl)-, and 5-(arylsulfonyl)thiophene-2-sulfonamides.

M. Parry, M. Randall, P. Cross, 1981, Journal of medicinal chemistry.

A potent, selective inhibitor of matrix metalloproteinase-3 for the topical treatment of chronic dermal ulcers.

N. Occleston, M. Fray, J. P. Huggins, 2003, Journal of medicinal chemistry.

Novel Antifungal 2-Aryl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol Derivatives with High Activity Against Aspergillus fumigatus.

A. Bell, P. Troke, C. Hitchcock, 1996 .

Cerebrovasodilatation through selective inhibition of the enzyme carbonic anhydrase. 2. Imidazo[2,1-b]thiadiazole and imidazo[2,1-b]thiazolesulfonamides.

M. Parry, M. Randall, P. Cross, 1980, Journal of medicinal chemistry.

Selective thromboxane synthetase inhibitors. 1. 1-[(Aryloxy)alkyl]-1H-imidazoles.

M. Parry, M. Randall, P. Cross, 1985, Journal of medicinal chemistry.

3-(1-imidazolylmethyl) indoles: potent and selective inhibitors of human blood platelet thromboxane synthetase

M. Parry, M. Randall, P. Cross, 1981, Agents and Actions.

Vinyl glycosides in oligosaccharide synthesis (part 4): glycosidase-catalysed preparation of substituted allyl glycosides

G. Boons, R. Dickinson, Robin R. Gibson, 1997 .

CHAPTER 9 – Synthesis and biological activity of prostaglandin analogues with modified ring systems

R. Dickinson, 1982 .

Thromboxane modulating agents. 3. 1H-imidazol-1-ylalkyl- and 3-pyridinylalkyl-substituted 3-[2-[(arylsulfonyl)amino]ethyl]benzenepropanoic acid derivatives as dual thromboxane synthase inhibitor/thromboxane receptor antagonists.

J. Steele, K. Dack, C. Long, 1997, Journal of medicinal chemistry.

Selective thromboxane synthetase inhibitors. 2. 3-(1H-imidazol-1-ylmethyl)-2-methyl-1H-indole-1-propanoic acid and analogues.

M. Parry, M. Randall, P. Cross, 1986, Journal of medicinal chemistry.

Reaction of benzo[b]thiophene-5- and 6-methanols with n-butyllithium. Directed lithiation in the benzene ring

P. Cross, R. Dickinson, 1985 .

Thromboxane modulating agents. 4. Design and synthesis of 3-(2-[[(4-chlorophenyl)sulfonyl]-amino]ethyl)benzenepropanoic acid derivatives as potent thromboxane receptor antagonists.

J. Steele, K. Dack, C. Long, 1998, Bioorganic & medicinal chemistry letters.

Thromboxane modulating agents. 2. Thromboxane receptor antagonists derived from the thromboxane synthase inhibitor dazmegrel.

M. Tute, J. Steele, K. Dack, 1996 .

Thromboxane modulating agents. 1. Design of 1-[(arylsulfonyl)amino] alkylindole derivatives as dual thromboxane synthase inhibitor/thromboxane receptor antagonists.

John Steele, J. Steele, K. Dack, 1995 .

Thromboxane Modulating Agents. Part 4. Design and Synthesis of 3-(2-[{(4-Chlorophenyl)sulfonyl}amino]ethyl)benzenepropanoic Acid Derivatives as Potent Thromboxane Receptor Antagonists.

J. Steele, K. Dack, C. Long, 1999 .

Reaction of Benzo[b]thiophene-5- and 6-Methanols with n-Butyllithium.

P. Cross, R. Dickinson, 1986 .

Concentration dependencies of immunoturbidimetric dose-response curves: immunoturbidimetric titer and reactivity, and relevance to design of turbidimetric immunoassays.

K. Agee, S. Shahangian, R. Dickinson, 1992, Clinical chemistry.

Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.

M. Fray, R. Dickinson, M. Burslem, 2001, Bioorganic & medicinal chemistry letters.

Selective urokinase-type plasminogen activator (uPA) inhibitors. Part 1: 2-Pyridinylguanidines.

V. A. Horne, C. Barber, R. Dickinson, 2002, Bioorganic & medicinal chemistry letters.

Discovery of potent and selective succinyl hydroxamate inhibitors of matrix metalloprotease-3 (stromelysin-1).

M. Fray, R. Dickinson, 2001, Bioorganic & medicinal chemistry letters.

SUBSTITUTED TRIFLUOROMETHYL PHENYL PIPERAZINES AS ANORECTIC AGENTS

G. Halliwell, P. Cross, R. Dickinson, 1977 .